Ming He
Impact in
-
- Cancer-related Molecular Pathways
-
- Cancer Research and Treatments
Papers in
- Surgery 12
- Esophageal Cancer Research and Treatment 11
-
- Lung Cancer Treatments and Mutations 7
- Gastric Cancer Management and Outcomes 7
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- Denggui Wen (4 shared papers)Rui Wang (3 shared papers)Jianhui Zhang (3 shared papers)Gang Kuang (3 shared papers)Lizhen Wei (3 shared papers)Yuxiang Wang (8 shared papers)Qi Zhan (8 shared papers)Mario Sarbia (2 shared papers)
In The Last Decade
Ming He
25 papers receiving 296 citations
Peers
Comparison fields: 5 of 35
- Oncology 139
- Biotechnology 29
- Surgery 98
- Cancer Research 30
- Molecular Biology 114
Countries citing papers authored by Ming He
This map shows the geographic impact of Ming He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming He more than expected).
Fields of papers citing papers by Ming He
This network shows the impact of papers produced by Ming He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming He. The network helps show where Ming He may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 73 | |
| 2 | 2003 | 68 | |
| 3 | 2010 | 23 | |
| 4 | [p53 gene polymorphism with susceptibility to esophageal cancer and lung cancer in Chinese population]. | 2003 | 17 |
| 5 | 2021 | 16 | |
| 6 | 2020 | 13 | |
| 7 | [The association of cyclin D1 (A870G) polymorphism with susceptibility to esophageal and cardiac cancer in north Chinese population]. | 2003 | 12 |
| 8 | 2015 | 12 | |
| 9 | 2020 | 11 | |
| 10 | 2021 | 7 | |
| 11 | [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer]. | 2003 | 7 |
| 12 | 2016 | 6 | |
| 13 | 2019 | 5 | |
| 14 | 1996 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2024 | 4 | |
| 17 | 2025 | 3 | |
| 18 | 2018 | 2 | |
| 19 | 2017 | 2 | |
| 20 | 2024 | 2 |
About Ming He
Ming He is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Molecular Biology, having authored 26 papers that have together received 302 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (11 papers), Lung Cancer Treatments and Mutations (7 papers), Gastric Cancer Management and Outcomes (7 papers), Lung Cancer Research Studies (3 papers), Cancer-related Molecular Pathways (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Multiple and Secondary Primary Cancers (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Oncology (139 citations), Biotechnology (29 citations), Surgery (98 citations), Cancer Research (30 citations) and Molecular Biology (114 citations). Ming He has collaborated with scholars based in China, Germany and Japan. Frequent co-authors include Denggui Wen, Rui Wang, Jianhui Zhang, Gang Kuang, Lizhen Wei, Yuxiang Wang, Qi Zhan, Mario Sarbia, Mingli Wu and Shijie Wang. Their work appears in journals such as Cancer Biotherapy and Radiopharmaceuticals, International Journal of Cancer, BioMed Research International, Frontiers in Veterinary Science and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.